title: Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.
abstract: BACKGROUND
  Cytogenetic abnormalities are important prognostic markers in plasma cell myeloma (PCM) and detection is routinely performed by interphase fluorescence in-situ hybridization (FISH) with a panel of probes after enrichment of the plasma cells in the bone marrow specimen. Cell sorting by immunomagnetic beads and concurrent labeling of the cytoplasmic immunoglobulin are the usual enrichment methods. We present an alternative method of plasma cell enrichment termed Target FISH, which is an automated system that combines the images of May-Grünwald- Giemsa (MGG) staining and FISH study on the same plasma cell for analysis.
  
  
  RESULTS
  Our experience of Target FISH on 40 PCM patients was described. Briefly, plasma cells were MGG stained, image captured, de-stained, FISH probe hybridized and finally relocated for simultaneous analysis of morphology and FISH signal pattern. The FISH probe panel was TP53/CEP17, t(4;14) IGH/FGFR3, t(14;16) IGH/MAF and CKS1B(1q21)/CDKN2C(P18). Gain of 1q21 was the most common abnormality detected in 18 patients (45 %), to be followed by t(4;14) IGH/FGFR3 detected in 11 patients (27.5 %). Of note, 10 patients showed coexistence of both t(4;14) and 1q21 gain. Two patients showed del(17p)/TP53, one in association with t(4;14) and 1q gain while the other was stand alone. None of this patient cohort showed t(14;16) IGH/MAF. Using the critical binomial function, the normal cutoff FISH positive value for del(17p)/TP53 was 3.4 %, t(4;14) IGH/FGFR3 was 6.8 %, t(14;16) IGH/MAF was 5.6 % and +1q21 was 5.7 %.
  
  
  CONCLUSIONS
  The equipment cost notwithstanding, when compared with cell sorting, the total reagent cost was around 10 % lower in Target FISH. The total processing time was longer for Target FISH but manual fluorescence microscopy was no longer necessary. The main advantage of Target FISH was the complete certainty that the cytogenetic abnormality was detected in the cells of interest, and hence a more stringent analytical cutoff value might be considered. Optimization of the cell collection and slide preparation process upfront was required to accrue adequate target cells on each slide for analysis. Our experience suggested that Target FISH was applicable as a routine method of plasma cell enrichment in clinical diagnostic laboratories.
authors.affiliation: Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Clinical Pathology Laboratory, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong.
authors.forename: Edmond S K
authors.initials: ES
authors.lastname: Ma
authors.affiliation: Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Clinical Pathology Laboratory, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong.
authors.forename: Candy L N
authors.initials: CL
authors.lastname: Wang
authors.affiliation: Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Clinical Pathology Laboratory, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong.
authors.forename: Anthony T C
authors.initials: AT
authors.lastname: Wong
authors.affiliation: Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Clinical Pathology Laboratory, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong.
authors.forename: Gigi
authors.initials: G
authors.lastname: Choy
authors.affiliation: Division of Molecular Pathology, Department of Pathology, Hong Kong Sanatorium & Hospital, Clinical Pathology Laboratory, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong.
authors.forename: Tsun Leung
authors.initials: TL
authors.lastname: Chan
keywords: Cell sorting; Cytogenetics; FISH; Laboratory automation; Molecular pathology; Plasma cell myeloma; Prognosis; Risk stratification